]>
IRCT2015121925601N4 IRCT 2016-01-04 Vice chancellor for research, Esfahan University of Medical Sciences Investigate the aromatherapy with damask rose extracts to reduce apnea in premature infants hospitalized in NICU ward of selected training hospitals of Esfahan in 2015 Effectiveness and ineffectiveness of aromatherapy with damask rose extracts to reduce apnea in premature infants hospitalized in NICU ward of selected training hospitals of Esfahan in 2015 2016-01-08 anticipated 60 Complete https://irct.ir/trial/21378 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Other design features: Randomly by tossing coin. N/A Apnea. Intervention 1: In the experimental group, in addition to conventional therapy,aromatherapy with damask rose extracts starton the second day of birth from 6Am and by pouring2 drops of damask rose extracts 10% on linen that is located at a distance of 3 cm of infant head then at, 9,12, 15, 18, o’clock will repeat. In each time the heart rate and arterial oxygen recorded by the monitoring device and episodes of apnea with direct observation will bechart and record . Intervention 2: In the control group in addition to conventional therapy, therapy on the second day of birth from 6Am and by pouring2 drops of Distilled water on linen that is located at a distance of 3 cm of infant head then at, 9.12, 15, 18, o’clock will repeat. In each time the heart rate and arterial oxygen recorded by the monitoring device and episodes of apnea with direct observation will be chart and record .
public Saeideh Agha Goli
Hazrate Masomeh Hospital, Before terminal, After Shahid Zeinodin Square
Ghom Iran (Islamic Republic of) +98 21636665553 Aghagoli1974@gmail.com Hazrate Masomeh Hospital scientific Zohreh Ghazavi
School of Nursing & Midwifery, Esfahan University of Medical Sciences, Hezarjarib Street
Esfahan Iran (Islamic Republic of) +98 31 3792 3060 ZOHRE_GHAZAVI@NM.MUI.AC.IR Esfahan University of Medical Sciences Iran (Islamic Republic of) Inclusion criteria: infants between 29-33 weeks gestational age; birth weight between 900-1500 grams; The baby's blood hemoglobin level higher than 10g /dl;infants Parental consent; Lack of oxygen uptake through cpAP; no need for infant ventilator; lack of heart disease or any infection. Exclusion criteria were: discharge or death of an infant before the end of the intervention period; the incidence of respiratory symptoms and skin allergy during the study. no limit no limit Both J98 Other diseases of the respiratory system Treatment - Drugs Placebo In the experimental group, in addition to conventional therapy,aromatherapy with damask rose extracts starton the second day of birth from 6Am and by pouring2 drops of damask rose extracts 10% on linen that is located at a distance of 3 cm of infant head then at, 9,12, 15, 18, o’clock will repeat. In each time the heart rate and arterial oxygen recorded by the monitoring device and episodes of apnea with direct observation will bechart and record . In the control group in addition to conventional therapy, therapy on the second day of birth from 6Am and by pouring2 drops of Distilled water on linen that is located at a distance of 3 cm of infant head then at, 9.12, 15, 18, o’clock will repeat. In each time the heart rate and arterial oxygen recorded by the monitoring device and episodes of apnea with direct observation will be chart and record . Heart rate. Timepoint: 24 hours after birth, and 9, 12, 15, 18 hours after the first 24 hours. Method of measurement: By monitoring device. Arterial blood oxygen saturation percent. Timepoint: 24 hours after birth, and 9, 12, 15, 18 hours after the first 24 hours. Method of measurement: By monitoring device. The number of episodes of apnea. Timepoint: 24 hours after birth, and 9, 12, 15, 18 hours after the first 24 hours. Method of measurement: By direct observation. Vice chancellor for research, Esfahan University of Medical Sciences Approved 2015-08-31 Committee Ethics, Esfahan University of Medical Sciences Vice Chancellor for Research Affairs, Esfahan University of Medical Sciences, Hezarjarib Street Esfahan Iran (Islamic Republic of)